-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Unicycive Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2022.
- Unicycive Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.16M, a 34.3% increase year-over-year.
- Unicycive Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$6K, a 99.4% increase from 2021.
- Unicycive Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.04M, a 326% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)